Sarepta Therapeutics, Inc.SRPTNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+14.1%
5Y CAGR+13.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+14.1%/yr
vs +21.5%/yr prior
5Y CAGR
+13.7%/yr
Consistent
Acceleration
-7.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.97B | +44.7% |
| 2024 | $1.36B | +0.3% |
| 2023 | $1.36B | +2.4% |
| 2022 | $1.33B | +24.9% |
| 2021 | $1.06B | +2.3% |
| 2020 | $1.04B | +1.1% |
| 2019 | $1.03B | +68.7% |
| 2018 | $610.47M | +110.2% |
| 2017 | $290.44M | +6.8% |
| 2016 | $272.02M | - |